ULLEM SCOTT B. (CVP, CFO) sold 16.2% of their position (7.70K shares) of EDWARDS LIFESCIENCES CORP on the open market
Open‑market sale worth $650.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/9/2025ACC: 0001225208-25-009797
Officer· CVP, CFO
Since Jul 2018
-7.70K
Net shares
Net seller
$650.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7.70K acquired · 15.40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.70K
Price / share
$59.26
Trade value
$456.28K
% of position
19.3%
12/9/2025
39.90K→47.60K
Common Stock
Direct
Shares
−7.70K
Price / share
$84.47
Trade value
$650.41K
% of position
16.2%
12/9/2025
47.60K→39.90K
Total
Net shares
+0.00
Net value
-$194.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/9/2025 | M · Option Exercise | +7.70K | $59.26 | $456.28K | 19.3% | 39.90K | 47.60K |
| Common Stock Direct | 12/9/2025 | S · Sale | −7.70K | $84.47 | $650.41K | 16.2% | 47.60K | 39.90K |
| Total | +0.00 | -$194.14K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Acquire)
Direct
Converts to
Common Stock
7.70K shares
Shares
−7.70K
Strike price
59.2567
Held after
39K
Exercisable
—
12/9/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Acquire) Direct | Common Stock7.70K shares | 12/9/2025 | M · Option Exercise | −7.70K | 59.2567 | — | 39K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned266.32K
Total
266.32K indirect266.32K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 266.32K | Indirect |
| Total | 266.32K | 266.32K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported